In addition to the activation of the PI3K pathway, the same study revealed high protein and phosphoprotein expression of both EGFR and Her2 within the Her2+ BC subtype, and both receptors have the ability to activate the Ras/MAPK pathway via GRB2 and SOS. The gene discussed is XYLT2; the disease is breast cancer.